Aortic stenosis and concomitant mitral valve disease

Anchorperson: M. Borger
Moderator: V. Delgado
SHOW MORE

Summary

Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.

Learning Objectives

  • To better understand how concomitant mitral valve disease influences clinical and procedural outcomes
  • To differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate
  • To gain insights into potential interventional options for concomitant mitral and aortic valve disease

Presentations available when logged in:

  • Session objectives
  • Case 1 - A high-risk patient with severe aortic stenosis and severe mitral regurgitation requiring TAVI and TEER
  • TAVI plus transcatheter mitral valve replacement
  • Case denouement
  • Case 2 - A low or intermediate risk patient with severe aortic stenosis and moderate primary MR
  • Case denouement